This study assessed the relationship between Insulin, glucose, body mass Index, and cardiovascular risk factors in a sample of 489 white premenopausal women. All women were participants In the Healthy Women Study (University of Pittsburgh) and had normal blood pressure and fasting blood glucose of less than 140 mg/dl and a 2-hour value after a 75-g glucose load of less than 200 mg/dl. Both body mass Index and fasting Insulin were significantly and independently associated with blood pressure, trlglycerldes, and high density lipoprotein (HDL) cholesterol and its subtractions. Body mass Index and fasting Insulin were more strongly associated with coronary heart disease (CHD) risk factors than were 2-hour Insulin, or fasting or 2-hour glucose; glucose levels did not contribute Independently to multlvaiiate predictions of any of the CHD risk factors. When patients were divided Into tertlles according to fasting Insulin and body mass Index, there were significant main effects of insulin and body mass Index on blood pressure, trlglycerldes, and HDL cholesterol and Its subtractions; the Interaction of Insulin times body mass Index was also significant for systolic blood pressure, trlglycerldes, and apoprotein B. These data confirm the previous findings of a strong association between Insulin and CHD risk factors and extend this to healthy premenopausal women. Obesity has been shown to be related to the risk of developing hypertension 1 -23 ; weight loss, with concomitant changes in insulin sensitivity, 4 has been shown to lower blood pressure. 56 Moreover, in both obese and nonobese study populations, hypertensives have been shown to have higher fasting and glucose-stimulated insulin levels than normotensives.
O besity, hypertension, lipid abnormalities, and disturbances in carbohydrate metabolism are often found in association with each other. The hyperinsulinemia of obese individuals may explain these relationships.
Obesity has been shown to be related to the risk of developing hypertension 1 -23 ; weight loss, with concomitant changes in insulin sensitivity, 4 has been shown to lower blood pressure. 56 Moreover, in both obese and nonobese study populations, hypertensives have been shown to have higher fasting and glucose-stimulated insulin levels than normotensives. 7 -89 A recent study documented insulin resistance in normal-weight, nondiabetic hypertensives. 10 These observations are supported by pathophysiobgical hypotheses; hyperinsulinemia may affect blood pressure by enhancing trie renal reabsorption of sodium, 11 by producing changes in the sympathetic nervous system, or both. 12 Conflicting data, however, are reported from the Paris Prospective Study I and II, where glucose levels were independently associated with blood pressure, but insulin was not. 1314 Insulin levels have also been related to plasma lipids and lipoproteins; positive correlations have been observed between insulin and triglycerides, and negative correlations, between insulin and high density lipoprotein (HDL) cholesterol. 151617 In a recent study with obese hyperinsulinemic subjects, insulin resistance was related to both triglycerides and HDL cholesterol, independent of adiposity. 18 Again, there are plausible physiological mechanisms to explain these relationships; triglycerides may influence insulin action 19 or, alternatively, insulin resistance may affect lipids through the effect of Insulin on lipoprotein lipase. 20 Although many of the previous studies of the relationship between insulin, glucose, blood pressure, and lipid levels have included women, none has considered the woman's menopausal status. Since the age range utilized has been extremely broad (e.g., 18 to 90 years), 6 both pre-and postmenopausal women have probably been included. Given that there may be changes in weight, lipids, and blood pressure at the time of the menopause, it is important to control for menopausal status in examining these interrelationships in women. Moreover, while evidence of a predictive role for insulin in atherosclerosis has been reported in three prospective studies, 21 -2223 only one of these studies included women, and in that study, 23 there was no relationship between insulin and coronary heart disease (CHD) risk in women, raising the possibility that insulin may not be as closely related to lipids, blood pressure, and cardiovascular disease in women as it is in men.
The aim of the present study was, therefore, to examine whether obesity, glucose, and insulin are related to blood pressure, lipids, and lipoproteins in healthy premenopausal women.
tigation of changes in cardiovascular risk factors that occur in healthy women at the time of the menopause. Women ages 42 to 52 years were recruited from a random sample of licensed drivers in selected zip codes of Allegheny County, PA. Of the 2119 women contacted, 89% (1885) agreed to an eligibility interview, and 891 met the following eligibility criteria: menstruating within the past 3 months, had not undergone surgical menopause, diastolic blood pressure (DBP) <100 mm Hg, and not taking lipid-lowering drugs, insulin, thyroid, estrogens, antihypertensive drugs, or psychotropic drugs. The primary reasons for ineligibility were surgical menopause, hypertension medication, and thyroid medication. Sixty percent (541) of those who were eligible were willing to participate in the study. Participants were well educated, with 26% attaining an advanced degree beyond college, 25% graduating from college, 22% attending some college, and 27% having a high school diploma or less. Participants were better educated than nonparticipants and ineligibles. 24 The characteristics of eligible participants and nonparticipants and ineligible subjects have been reported elsewhere. 24 The present study is based on the 489 white women who entered the study and had nondiabetic blood glucose levels (i.e., fasting blood glucose of less than 140 mg/dl and 2-hour values after a 75-g glucose load of less than 200 mg/dl).
Procedures
All women were studied initially between November 1983 and April 1985 at the University of Pittsburgh. Participants were studied in the morning after a 12-hour fast. This visit included the following measures:
1 triglycerides, 28 and apolipoproteins (apo) A-l, B, and A-ll. Apo A-l and Apo B were assessed by electroimmunoassay 28 and apo A-ll, 30 by enzymelinked immunoabsorbent assay. 2. Glucose and insulin. These measures were obtained after fasting and 2 hours after a 75-g oral glucose load. Plasma glucose was analyzed by enzymatic assay (Yellow Springs Glucose Analyzer, Yellow Springs Instruments, Yelbw Springs, OH) and plasma insulin, by radioimmunoassay. 31 3. Blood pressure. Blood pressure was measured with a random zero muddler by observers trained and certified according to the Multiple Risk Factor Intervention Trial (MRFIT) protocol. 32 Three measures were obtained, and the last two were averaged. The entire procedure was conducted at the start of the screening sessions and 2 hours later; the results of these two blood pressure assessments were averaged. Results Table 1 presents the means and standard deviations for glucose, insulin, BMI, and the CHD risk factors under investigation. The means for BMI and total HDL cholesterol were similar to those observed for white women in the Lipid Research Clinics Prevalence Study (LRC). 33 Blood pressure, total cholesterol, and triglycerides were slightly lower than in the LRC study, probably reflecting the exclusion of hypertensive and diabetic subjects in the present study.
Due to the skewed distribution of insulin and triglycerides, these variables were log-transformed for data analysis. Univariate correlations between BMI, insulin, glucose, and the CHD risk factors are shown in Table 2 . These correlations showed the following: BMI was significantly (/X0.001) correlated with all of the CHD risk factors, with the exception of cholesterol and APO A-ll. Fasting Insulin was also strongly related to blood pressure and lipids and, in fact, showed correlations with these variables that were similar in magnitude to those seen for BMI. BMI and fasting insulin were more strongly related to the CHD risk factors than the 2-hour insulin, or the fasting or 2-hour glucose values.
To determine which of these variables contributed Independently to the prediction of the CHD risk factors, step-wise multiple regression analyses were conducted using BMI, fasting insulin, and fasting glucose values as the predictors. The variables that contributed significantly to the prediction of the CHD risk factors are shown in Table 3 . BMI and insulin both contributed Independently to the prediction of all of the risk factors, with the exception of cholesterol and APO A-l and APO A-ll. It is important to note that glucose did not contribute to the prediction of any of these variables. Once insulin and BMI were in the regression model, the interaction of these two variables did not contribute significantly. To further examine the relationship between BMI, insulin, and the CHD risk factors, subjects were divided into tertiles for fasting insulin levels and for BMI. Table 4 shows the cut-offs for the tertiles, the distribution of women in the various tertiles, and the BMI, insulin level, and CHD risk factors for each fertile. variance was then conducted on each of the blood pressure and lipid measures to examine the effects of insulin and BMI and the interaction of insulinxBMI. In agreement with the regression analyses described above, these analyses showed significant main effects of both BMI and insulin on systolic and diastolic blood pressure, triglycerides, and HDL cholesterol and its subtractions. In the fertile analyses, the interaction of BMIxinsulin also was significant for systolic blood pressure (SBP) (p<0.04), triglycerides (p<0.001), and apolipoprotein B (APO B) (p<0.03). The significant interaction of BMI and insulin tertiles on blood pressure, triglycerides, and APO B are graphed in Figures 1 to 3 . For each of these measures, there was no effect of insulin levels in subjects in the lowest BMI fertile, and no effect of BMI in subjects in the lowest insulin fertile. However, in the middle and upper tertiles, both insulin and BMI had an effect on the risk factor. When regression analyses were done for each fertile separately, it was shown that in the lowest fertile of BMI, the slope of the regression line predicting SBP, triglycerides, or APO B from insulin levels was not significant. Similarly, in the lowest fertile of insulin, the slope of the regression line predicting SBP, triglyceride, or APO B by BMI was not significant. In contrast, in the middle and high insulin tertiles and in the middle and high BMI tertiles, the slopes of the regression lines were all significant (p ranging from <0.02 to <0.0001). The tests for equality of the slopes showed that, in all cases except SBP by BMI, the slope of the regression lines for the low, medium, and high tertiles differed significantly (p ranging from <0.05 to <0.001).
Twenty-four subjects were not diabetic, but exhibited impaired glucose tolerance by the World Health Organi- zation criteria [fasting blood sugar (FBS) <140 mg/dl and 2-hour FBS 140 to 200 mg/dl]. When these subjects were compared to other subjects with normal glucose tolerance, the glucose-intolerant subjects were found to have higher SBP, triglycerides, HDL cholesterol, HDL 2 subtraction, and APO B levels ( Table 5 ). The glucose-intolerant subjects also had higher insulin levels after fasting and 2 hours after the glucose load, and they were fatter than those with normal glucose tolerance. After adjusting for differences in body weight or BMI, the difference between normal and impaired glucose-tolerant (IGT) subjects remained significant for triglycerides, APO B, and insulin levels 2 hours after the glucose load.
When patients with IGT were removed from the data, the correlations between insulin, BMI, glucose, and the CHD risk factors reported in Table 2 remained unchanged.
Discussion
The results reported in this study suggest that in healthy, premenopausal women, both BMI and fasting insulin are independently related to SBP and DBP, triglycerides, HDL cholesterol and its subtractions, and to APO B. In contrast, glucose levels did not contribute independently to the prediction of any of these cardiovascular risk factors.
These data contrast sharply with previous reports from the Paris Prospective Study 1314 but confirm other analyses, suggesting that insulin, rather than glucose, is related to blood pressure and lipid levels.
81617 Moreover, this study shows that the relationship between insulin and cardiovascular risk factors occurs in healthy women, who have both normal blood pressure levels and normal glucose tolerance. This paper confirms prior studies showing that insulin is positively correlated with triglycerides and negatively correlated with HDL cholesterol. 1718 In this study, insulin contributed independently to the prediction of both subfractions of HDL, HDLz and HDL 3 . We are not aware of other studies investigating the insulin levels and apoprotein levels. In this study, we found that insulin was related most strongly to APO B, consistent with the strong relationship between insulin and triglycerides.
Both insulin and BMI contributed independently to the prediction of DBP, HDL cholesterol, and the HDL 2 subfraction. For these measures, the interaction between insulin and BMI was not significant, suggesting that for any given level of insulin, an increase in BMI was associated with a worsening of DBP or HDL cholesterol; similarly, at any level of BMI, an increase in insulin was associated with a worsening in DBP or HDL cholesterol.
In contrast, this study suggests an interaction between insulin and BMI in relationship to SBP, triglycerides, and APO B. Women in the lowest fertile of either insulin or BMI showed no effect of increased levels of the other variable. Thus, for women in the lowest fertile, there does not appear to be a deleterious effect of the other variable, while for women In the middle and upper level of BMI and Insulin, an increase in either obesity or insulin is associated with an increase in SBP, triglycerides, or APO B. Further studies are needed to determine whether this interaction effect is seen in other samples, and particularly whether the interaction is apparent in men as well as women.
In interpreting the results of this study, the nature of the sample should be considered; these women were healthy and relatively well educated. In addition, the current study was based on white participants only. The fact that hypertensive and diabetic subjects were excluded may well have lowered the lipid and blood pressure levels of the sample compared to national population samples. 33 Further studies are needed to determine whether it is changes in insulin or body weight per se, that are responsible for the changes in liptds and Wood pressure that accompany weight toss. 56 - 34 Prior studies have suggested that the effects of exercise on improvement in blood pressure are most apparent in patients who were hyperinsulinemic at pretreatment 35 ; similarly, the effects of weight loss may be most pronounced in obese, hyperinsuinemic patients. In the Healthy Women Study, women will be reassessed after becoming postmenopausal and will be compared to age-matched, still-premenopausal controls. An interesting aspect of this follow-up will be to determine whether the relationships observed for premenopausal women will continue to appear in the postmenopausal period. In addition, it will be interesting to determine whether change in BMI, insulin, or both contributes to change in CHD risk factors.
